Pharmaceutical formulations
US10653781B2 · kind B2 · utility
0Cited by
33References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2016 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Dec 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.